Cemsidomide (CFT7455)

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

Near Add Your Location

  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
Alvin J. Siteman Cancer Center
Washington University Medical Campus
St. Louis, MO
  • Accepting patients
  • Show Principal Investigator
Mount Sinai Hospital
Tisch Cancer Institute
New York, NY
  • Accepting patients
  • Show Principal Investigator
Sarah Cannon Research Institute at Tennessee Oncology
TriStar Centennial Medical Center
Nashville, TN
  • Accepting patients
  • Show Principal Investigator
  • Accepting patients
  • Show Principal Investigator
Colorado Blood Cancer Institute
Sarah Cannon at Presbyterian/St. Luke's Medical Center (HealthONE)
Denver, CO
  • Accepting patients
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.